What is West Pharmaceutical Services 10-Year ROIIC %?
10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year.
West Pharmaceutical Services's 10-Year ROIIC % for the quarter that ended in Dec. 2023 was 35.42%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* Premium members only.
West Pharmaceutical Services 10-Year ROIIC % Chart
Competitive Comparison of West Pharmaceutical Services's 10-Year ROIIC %
For the Medical Instruments & Supplies subindustry, West Pharmaceutical Services's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
West Pharmaceutical Services's 10-Year ROIIC % Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, West Pharmaceutical Services's 10-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where West Pharmaceutical Services's 10-Year ROIIC % falls into.
West Pharmaceutical Services 10-Year ROIIC % Calculation
10-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
10-Year Incremental Invested Capital**
=
( 583.46352 (Dec. 2023) - 117.65273 (Dec. 2013) )
/
( 2551.4 (Dec. 2023) - 1236.2 (Dec. 2013) )
=
465.81079
/
1315.2
=
35.42%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
West Pharmaceutical Services (NYSE:WST) 10-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
West Pharmaceutical Services 10-Year ROIIC % Related Terms
Thank you for viewing the detailed overview of West Pharmaceutical Services's 10-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.
West Pharmaceutical Services (West Pharmaceutical Services) Business Description
West Pharmaceutical Services is a Pennsylvania-based medical supplies company that operates as a key supplier to firms in the pharmaceutical, biotechnology, and generic drug industries. West develops, manufactures, and distributes elastomer-based supplies for the containment and administration of injectable drugs, including basic equipment such as syringes, stoppers, and plungers, along with somewhat more complicated devices including auto-injectors and other self-injection platforms. The company reports in two segments: proprietary products (82% of 2021 sales) and contract-manufactured products (18%). It generates 55% of its revenue from international markets and 45% from the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
WST has been successfully added to your 